Wave Life Sciences Files 8-K
Ticker: WVE · Form: 8-K · Filed: Sep 3, 2025 · CIK: 1631574
| Field | Detail |
|---|---|
| Company | Wave Life Sciences Ltd. (WVE) |
| Form Type | 8-K |
| Filed Date | Sep 3, 2025 |
| Risk Level | low |
| Pages | 2 |
| Reading Time | 3 min |
| Key Dollar Amounts | $0 |
| Sentiment | neutral |
Sentiment: neutral
Topics: disclosure, financials
TL;DR
Wave Life Sciences filed an 8-K on Sept 3, 2025, covering disclosures and financials.
AI Summary
Wave Life Sciences Ltd. filed an 8-K on September 3, 2025, reporting on various events. The filing includes information related to Regulation FD Disclosure, Other Events, and Financial Statements and Exhibits. The company is incorporated in Singapore and its fiscal year ends on December 31.
Why It Matters
This 8-K filing provides updates on company events and financial disclosures, which are important for investors to understand the latest developments at Wave Life Sciences Ltd.
Risk Assessment
Risk Level: low — This filing is a routine 8-K report and does not appear to contain any specific material events that would inherently increase risk.
Key Players & Entities
- Wave Life Sciences Ltd. (company) — Registrant
- September 3, 2025 (date) — Date of earliest event reported
- Singapore (location) — State of incorporation
FAQ
What is the primary purpose of this 8-K filing?
This 8-K filing serves as a Current Report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934, reporting on various events including Regulation FD Disclosure, Other Events, and Financial Statements and Exhibits.
When was the earliest event reported in this filing?
The earliest event reported in this filing occurred on September 3, 2025.
Where is Wave Life Sciences Ltd. incorporated?
Wave Life Sciences Ltd. is incorporated in Singapore.
What is the fiscal year end for Wave Life Sciences Ltd.?
The fiscal year end for Wave Life Sciences Ltd. is December 31.
What are the main sections covered by this 8-K filing?
The main sections covered by this 8-K filing are Regulation FD Disclosure, Other Events, and Financial Statements and Exhibits.
Filing Stats: 641 words · 3 min read · ~2 pages · Grade level 9.8 · Accepted 2025-09-03 07:40:03
Key Financial Figures
- $0 — of each exchange on which registered $0 Par Value Ordinary Shares WVE The N
Filing Documents
- d67509d8k.htm (8-K) — 27KB
- d67509dex991.htm (EX-99.1) — 25KB
- g67509g0903093439139.jpg (GRAPHIC) — 3KB
- 0001193125-25-194511.txt ( ) — 177KB
- wve-20250903.xsd (EX-101.SCH) — 3KB
- wve-20250903_lab.xml (EX-101.LAB) — 18KB
- wve-20250903_pre.xml (EX-101.PRE) — 11KB
- d67509d8k_htm.xml (XML) — 4KB
Financial Statements and Exhibits
Financial Statements and Exhibits. (d) Exhibits The following exhibit relating to Item 7.01 is furnished and not filed: Exhibit No. Description 99.1 Press Release issued by Wave Life Sciences Ltd. dated September 3, 2025 104 Cover Page Interactive Data File (embedded within the Inline XBRL document)
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. WAVE LIFE SCIENCES LTD. By: /s/ Paul B. Bolno, M.D. Paul B. Bolno, M.D. President and Chief Executive Officer Date:September 3, 2025